1. Home
  2. IBO vs XYLO Comparison

IBO vs XYLO Comparison

Compare IBO & XYLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IBO
  • XYLO
  • Stock Information
  • Founded
  • IBO 2018
  • XYLO 1999
  • Country
  • IBO United States
  • XYLO Israel
  • Employees
  • IBO N/A
  • XYLO N/A
  • Industry
  • IBO
  • XYLO
  • Sector
  • IBO
  • XYLO
  • Exchange
  • IBO NYSE
  • XYLO NYSE
  • Market Cap
  • IBO 5.8M
  • XYLO 6.2M
  • IPO Year
  • IBO 2024
  • XYLO N/A
  • Fundamental
  • Price
  • IBO $0.69
  • XYLO $5.05
  • Analyst Decision
  • IBO
  • XYLO
  • Analyst Count
  • IBO 0
  • XYLO 0
  • Target Price
  • IBO N/A
  • XYLO N/A
  • AVG Volume (30 Days)
  • IBO 635.2K
  • XYLO 7.2K
  • Earning Date
  • IBO 08-23-2025
  • XYLO 09-19-2025
  • Dividend Yield
  • IBO N/A
  • XYLO N/A
  • EPS Growth
  • IBO N/A
  • XYLO N/A
  • EPS
  • IBO N/A
  • XYLO N/A
  • Revenue
  • IBO N/A
  • XYLO $29,858,000.00
  • Revenue This Year
  • IBO N/A
  • XYLO $279.19
  • Revenue Next Year
  • IBO N/A
  • XYLO N/A
  • P/E Ratio
  • IBO N/A
  • XYLO N/A
  • Revenue Growth
  • IBO N/A
  • XYLO N/A
  • 52 Week Low
  • IBO $0.36
  • XYLO $2.70
  • 52 Week High
  • IBO $6.17
  • XYLO $6.67
  • Technical
  • Relative Strength Index (RSI)
  • IBO N/A
  • XYLO 50.23
  • Support Level
  • IBO N/A
  • XYLO $4.91
  • Resistance Level
  • IBO N/A
  • XYLO $5.19
  • Average True Range (ATR)
  • IBO 0.00
  • XYLO 0.16
  • MACD
  • IBO 0.00
  • XYLO 0.01
  • Stochastic Oscillator
  • IBO 0.00
  • XYLO 60.87

About IBO IMPACT BIOMEDICAL INC

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in four segments are: Corporate, Online advertising & internet traffic routing, Online event management, real-estate and electronics. The company's geographical segments include USA, Europe, Great Britain, Israel, Canada, Asia and others.

Share on Social Networks: